Abstract
P19-77 Comparing non-clinical safety studies to pharmacovigilance evaluation for assessment of safety: the case of anti-COVID-19 vaccines in France
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have